Vir Biotechnology (VIR) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.17
-0.81
-0.45
-0.1

Details

Expected EPS
-0.0955
Actual EPS
-0.85
Surprise EPS
-0.75
Surprise Percent
+790.05%

Description

Vir Biotechnology (VIR) has reported earnings of -0.85 per share for Q2 2026.

0 Comments

Share your thoughts